Prognostic Impact of Multiple Prior Percutaneous Coronary Interventions in Patients Undergoing Coronary Artery Bypass

Fausto Biancari1,2, Magnus Dalén3, Vito G Ruggieri4

  • 11 Department of Surgery Oulu University Hospital and University of Oulu Finland.

Insights

Multiple prior percutaneous coronary interventions (PCI) do not increase early adverse events in patients undergoing coronary artery bypass grafting (CABG). This study found no significant difference in mortality or outcomes based on the number of prior PCI procedures.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Prior percutaneous coronary interventions (PCI) are often presumed to worsen outcomes in patients undergoing coronary artery bypass grafting (CABG).
  • Limited data exist to support or refute this assumption, necessitating further investigation.

Purpose of the Study:

  • To evaluate the association between multiple prior PCI procedures and early adverse events in patients undergoing isolated CABG.
  • To determine if the number of prior PCI or vessels treated impacts outcomes after CABG.

Main Methods:

  • Analysis of data from the prospective, multicenter E-CABG registry.
  • Inclusion of 6563 patients undergoing CABG, with stratification based on prior PCI history (>30 days before surgery).
  • Multivariable analysis to assess early mortality and other outcomes, adjusting for relevant factors.

Main Results:

  • 18.0% of patients had undergone PCI >30 days before CABG, with 11.6% having single PCI, 4.4% double PCI, and 2.1% triple or more PCI.
  • No significant differences in adjusted hospital/30-day mortality rates were observed across groups with varying numbers of prior PCI (1.8% vs. 1.9% vs. 1.4% vs. 2.5%, P=0.8).
  • Similarly, no significant differences in mortality were found based on the number of main coronary vessels treated with prior PCI (2.0% vs. 1.3% vs. 3.1%, P=0.6).

Conclusions:

  • Multiple prior PCI procedures are not associated with an increased risk of early adverse events in patients undergoing isolated CABG.
  • These findings are conditional on patient survival post-PCI and do not advocate for prioritizing multiple PCI over earlier CABG.
  • Further research may explore long-term outcomes and the impact of PCI timing on CABG success.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
451
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
269
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
373
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
693
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.3K